Roche
-
FDA Give Approval To Roche Multiple Sclerosis Drug Ocrevus
-
Ocrelizumab Shown Effective Against Relapsing, Progressive Forms Of Multiple Sclerosis
-
FDA Grants Roche’s Giant Cell Arteritis Drug Actemra Breakthrough Status
-
Roche Receives Emergency Use Authorization From FDA For LightMix Zika Test
-
Roche's Blood Cancer Drug Gazyva Fails To Meet Main Endpoints
-
Bladder Cancer Drug Atezolizumab Proved To Be Effective As Initial Treatment
-
Roche Drops Out Of 'Superbug' Antibiotic Project
-
Roche-Genentech Working On Precision Drug Therapy That Could Combat MRSA Infection
-
Roche Drug Ocrelizumab Proves Effective Against Multiple Sclerosis In Three Late-Stage Studies
-
Roche's MS Drug Ocrelizumab Shows Promising Results After Late Stage Trials
-
Experimental Drug Ocrelizumab Proves Successful Against Hard-To-Treat Type Of Multiple Sclerosis
-
New Drug Atezolizumab Shrinks Lung And Bladder Cancer Tumor Claims Roche
Most Popular
